These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35521006)

  • 21. Comparison of injectable anticoagulants for thromboprophylaxis after cancer-related surgery.
    Changolkar A; Menditto L; Shah M; Puto K; Farrelly E
    Am J Health Syst Pharm; 2014 Apr; 71(7):562-9. PubMed ID: 24644116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospital-based costs associated with venous thromboembolism prophylaxis regimens.
    Merli G; Ferrufino CP; Lin J; Hussein M; Battleman D
    J Thromb Thrombolysis; 2010 May; 29(4):449-58. PubMed ID: 19847624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
    Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
    J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of Symptomatic Venous Thromboembolisms in Stroke Patients.
    Al Turk M; Abraham M
    J Intensive Care Med; 2024 Mar; ():8850666241242683. PubMed ID: 38529544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initiative to improve thromboprophylactic enoxaparin exposure in hospitalized patients with renal impairment.
    Elsaid KA; Collins CM
    Am J Health Syst Pharm; 2012 Mar; 69(5):390-6. PubMed ID: 22345418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis.
    Shorr AF; Kwong LM; Sarnes M; Happe L; Farrelly E; Mody-Patel N
    Thromb Res; 2007; 121(1):17-24. PubMed ID: 17449088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost and occurrence of thrombocytopenia in patients receiving venous thromboembolism prophylaxis following major orthopaedic surgeries.
    Happe LE; Farrelly EM; Stanford RH; Sarnes MW
    J Thromb Thrombolysis; 2008 Oct; 26(2):125-31. PubMed ID: 18034323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic Venous Thromboembolism Prophylaxis in Patients with Nontraumatic Subarachnoid Hemorrhage Requiring an External Ventricular Drain.
    Ukpabi C; Sadan O; Shi Y; Greene KN; Samuels O; Mathew S; Joy J; Mei Y; Asbury W
    Neurocrit Care; 2024 May; ():. PubMed ID: 38730118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period.
    Middleton P; Shepherd E; Gomersall JC
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001689. PubMed ID: 33779986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study.
    Al Sulaiman K; Aljuhani O; Korayem GB; Hafiz A; Alalawi M; Badreldin HA; Altebainawi AF; Vishwakarma R; Alissa A; Alghamdi A; Alenazi AA; Al Enazi H; Alanazi S; Alhammad A; Alghamdi J; AlFaifi M; Al Sehli FA; Aldossari MA; Alhubaishi AA; Al-Ali AY; Al-Dorzi HM
    Thromb J; 2022 Dec; 20(1):74. PubMed ID: 36482388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.
    Fowler RA; Mittmann N; Geerts W; Heels-Ansdell D; Gould MK; Guyatt G; Krahn M; Finfer S; Pinto R; Chan B; Ormanidhi O; Arabi Y; Qushmaq I; Rocha MG; Dodek P; McIntyre L; Hall R; Ferguson ND; Mehta S; Marshall JC; Doig CJ; Muscedere J; Jacka MJ; Klinger JR; Vlahakis N; Orford N; Seppelt I; Skrobik YK; Sud S; Cade JF; Cooper J; Cook D; ;
    JAMA; 2014 Nov; 312(20):2135-45. PubMed ID: 25362228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and Efficacy of High-Dose Unfractionated Heparin Versus High-Dose Enoxaparin for Venous Thromboembolism Prevention in Morbidly Obese Hospitalized Patients.
    Mason SW; Barber A; Jones E; Chen SL; Moll S; Northam K
    Am J Med; 2020 Jun; 133(6):e249-e259. PubMed ID: 31862336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis.
    Mismetti P; Quenet S; Levine M; Merli G; Decousus H; Derobert E; Laporte S
    Chest; 2005 Oct; 128(4):2203-10. PubMed ID: 16236875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Enoxaparin for Inpatient Venous Thromboembolism Prophylaxis in End-Stage Renal Disease Patients on Hemodialysis.
    Sacks J; Luc SA
    Hosp Pharm; 2021 Dec; 56(6):718-724. PubMed ID: 34732929
    [No Abstract]   [Full Text] [Related]  

  • 37. Retrospective Evaluation of Venous Thromboembolism Prophylaxis in Elderly, High-Risk Trauma Patients.
    Krantz EN; Philpott CD; Droege ME; Mueller EW; Ernst NE; Garber PM; Tsuei BJ; Goodman MD; Droege CA
    J Surg Res; 2020 May; 249():225-231. PubMed ID: 31991331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-molecular-weight heparin versus unfractionated heparin in the treatment of patients with acute pulmonary thromboembolism.
    Findik S; Erkan ML; Selçuk MB; Albayrak S; Atici AG; Doru F
    Respiration; 2002; 69(5):440-4. PubMed ID: 12232452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurological outcomes in patients with ischemic stroke receiving enoxaparin or heparin for venous thromboembolism prophylaxis: subanalysis of the Prevention of VTE after Acute Ischemic Stroke with LMWH (PREVAIL) study.
    Kase CS; Albers GW; Bladin C; Fieschi C; Gabbai AA; O'Riordan W; Pineo GF;
    Stroke; 2009 Nov; 40(11):3532-40. PubMed ID: 19696423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Effectiveness and Costs of Enoxaparin Monotherapy Versus Unfractionated Heparin Monotherapy in Treating Acute Coronary Syndrome.
    Rosenthal N; Xiao Z; Kartashov A; Levorsen A; Shah BR
    Am J Cardiovasc Drugs; 2021 Jan; 21(1):93-101. PubMed ID: 32578166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.